As Wegovy patent ends in India, generic drugs flood a niche market

Nikkei Asia | March 26, 2026, 1:58 a.m. | Original

BENGALURU -- Ameya Nagarajan forks out nearly 25,000 rupees ($270) every month for weight-loss drugs, 20% more than the average monthly income of a salaried Indian.

Indonesia deflects airlines' requests to raise airfare caps Taiwan's Kinsus bets billions to keep pace with Nvidia and TSMC's AI plans